SCHEMBL14024820

SCHEMBL14024820

Cn1cc(-c2cncc(Oc3ccc4nc(NC5CCCCC5)sc4c3)n2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 13/20 0.50
PDGFRB P09619 2/20 0.43
KIT P10721 2/20 0.43
PDGFRA P16234 2/20 0.43
FLT3 P36888 2/20 0.43
NTRK1 P04629 2/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
ITK Q08881 1/20 0.41
KDR P35968 2/20 0.40
PKM P14618 1/20 0.40
RET P07949 1/20 0.40
EPHB2 P29323 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR4 P22455 1/20 0.38
FGFR3 P22607 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14024830 0.90 CSF1R (0.48) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2851744 0.88 CSF1R (0.52) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024828 0.85 CSF1R (0.52) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024835 0.85 CSF1R (0.45) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14396675 0.85 CSF1R (0.53) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2676785 0.85 CSF1R (0.53) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024821 0.84 CSF1R (0.61) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024819 0.84 CSF1R (0.52) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024823 0.83 CSF1R (0.47) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL14024842 0.82 CSF1R (0.54) CSF1RPDGFRBKITPDGFRAFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008144062-A1 CSF-1R INHIBITORS, COMPOSITIONS, AND METHODS OF USE NOVARTIS AG (CH) 2008-11-27 WO disclosed